Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics (Nasdaq: AKBA) announced it will release its third quarter 2024 financial results on Thursday, November 7, 2024, before market open. The company will host a conference call at 8:00 a.m. EST on the same day to discuss financial results and recent business highlights. Investors can access the call through a registration link and are encouraged to dial in 15 minutes before the scheduled start time. A live webcast and archive will be available through the company's investor relations website.
Akebia Therapeutics (Nasdaq: AKBA) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 giovedì 7 novembre 2024, prima dell'apertura del mercato. L'azienda ospiterà una conference call alle 8:00 a.m. EST lo stesso giorno per discutere i risultati finanziari e i recenti punti salienti aziendali. Gli investitori possono accedere alla chiamata tramite un link di registrazione e sono incoraggiati a collegarsi 15 minuti prima dell'orario di inizio programmato. Un webcast dal vivo e un archivio saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda.
Akebia Therapeutics (Nasdaq: AKBA) anunció que publicará sus resultados financieros del tercer trimestre de 2024 el jueves 7 de noviembre de 2024, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica a las 8:00 a.m. EST el mismo día para discutir los resultados financieros y los aspectos destacados recientes del negocio. Los inversores pueden acceder a la llamada a través de un enlace de registro y se les anima a conectarse 15 minutos antes de la hora programada. Se dispondrá de una transmisión en vivo y un archivo a través del sitio web de relaciones con inversores de la empresa.
Akebia Therapeutics (Nasdaq: AKBA)는 2024년 3분기 재무 결과를 2024년 11월 7일 목요일, 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오전 8시에 재무 결과 및 최근 비즈니스 하이라이트에 대해 논의하기 위해 컨퍼런스 콜을 개최합니다. 투자자는 등록 링크를 통해 콜에 접속할 수 있으며, 예정된 시작 시간 15분 전에 연결할 것을 권장합니다. 회사의 투자자 관계 웹사이트를 통해 생중계 및 아카이브가 제공될 예정입니다.
Akebia Therapeutics (Nasdaq: AKBA) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le jeudi 7 novembre 2024, avant l'ouverture du marché. L'entreprise organiser une conférence téléphonique à 8h00 EST le même jour pour discuter des résultats financiers et des points forts récents de l'entreprise. Les investisseurs peuvent accéder à l'appel via un lien d'inscription et sont encouragés à se connecter 15 minutes avant l'heure de début prévue. Une diffusion en direct ainsi qu'un archivage seront disponibles sur le site des relations avec les investisseurs de l'entreprise.
Akebia Therapeutics (Nasdaq: AKBA) gab bekannt, dass die finanziellen Ergebnisse für das dritte Quartal 2024 am Donnerstag, den 7. November 2024, vor Markteröffnung veröffentlicht werden. Das Unternehmen wird am gleichen Tag um 8:00 Uhr EST eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse und die jüngsten Geschäfts-Highlights zu erörtern. Investoren können über einen Registrierungslink an der Konferenz teilnehmen und werden ermutigt, sich 15 Minuten vor der geplanten Startzeit einzuwählen. Eine Live-Übertragung und ein Archiv werden über die Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
Akebia to Host Conference Call on November 7, 2024, at 8:00 a.m. EST
Akebia will host a conference call on Thursday, November 7, 2024, at 8:00 a.m. EST to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-third-quarter-2024-financial-results-and-discuss-recent-business-highlights-302293581.html
SOURCE Akebia Therapeutics, Inc.
FAQ
When will Akebia Therapeutics (AKBA) report Q3 2024 earnings?
What time is Akebia Therapeutics (AKBA) Q3 2024 earnings call?
How can investors access Akebia Therapeutics (AKBA) Q3 2024 earnings call?
